BioTech Tools S.A.

Quick facts

Phase 3 pipeline

• gpASIT+TM · Oncology
  gpASIT+TM is a personalized immunotherapy that uses a patient's own immune cells to target and destroy cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BioTech Tools S.A. portfolio CI brief
• BioTech Tools S.A. pipeline updates RSS